GQG Partners
BIO icon

GQG Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History

GQG Partners’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-347
Closed -$259K – 86
2021
Q3 		$259K Buy
+347
New +$260K ﹤0.01% 83
2020
Q4 		– Sell
-354,266
Closed -$183M – 63
2020
Q3 		$183M Buy
354,266
+58,693
+20% +$29.7M 0.62% 41
2020
Q2 		$133M Buy
+295,573
New +$130M 0.59% 41
2020
Q1 		– Sell
-568
Closed -$210K – 63
2019
Q4 		$210K Buy
+568
New +$200K ﹤0.01% 57

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

GQG Partners's BIO Position: Q4 2021 in Review

GQG Partners sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2021, closing a stake of 347 shares — an estimated $259K sold.

GQG Partners first reported a position in BIO in Q4 2019 and held it in 4 quarters. The position peaked at $183M in Q3 2020. 533 funds tracked by Wall St. Rank hold BIO as of Q4 2021.

  • GQG Partners reported no remaining Bio-Rad Laboratories Class A position as of Q4 2021 after selling out during the quarter.
  • GQG Partners sold 347 Bio-Rad Laboratories Class A shares in Q4 2021, an estimated $259K.
  • GQG Partners first reported a position in Bio-Rad Laboratories Class A in Q4 2019 and held it in 4 quarters.
  • GQG Partners's Bio-Rad Laboratories Class A position peaked at $183M in Q3 2020.
  • 533 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2021.

Based on GQG Partners's 13F filing for Q4 2021, filed 14 Feb 2022.